Scholar Rock Holding Revenue 2017-2022 | SRRK
Scholar Rock Holding revenue from 2017 to 2022. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Scholar Rock Holding Annual Revenue
(Millions of US $) |
| 2021 |
$19 |
| 2020 |
$15 |
| 2019 |
$20 |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$0 |
Scholar Rock Holding Quarterly Revenue
(Millions of US $) |
| 2022-09-30 |
|
| 2022-06-30 |
|
| 2022-03-31 |
$33 |
| 2021-12-31 |
$4 |
| 2021-09-30 |
$5 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
$3 |
| 2020-09-30 |
$3 |
| 2020-06-30 |
$4 |
| 2020-03-31 |
$5 |
| 2019-12-31 |
$8 |
| 2019-09-30 |
$5 |
| 2019-06-30 |
$5 |
| 2019-03-31 |
$3 |
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.637B |
$0.019B |
|
Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States.
|
